Loading…
Loading…
ICUI does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ICUI and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ICUI and 80,000+ other tickers.
See exactly how ICUI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ICUI and 80,000+ other tickers.
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system…
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.
BlackRock Inc. acquired a new position in shares of ICU Medical, Inc. (NASDAQ: ICUI) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,753,409 shares of the medical instruments supplier's stock, valued at approximately $550,250,000. BlackRock Inc. owned about 15.02% of ICU
Emerald Investment Advisers LLC acquired a new stake in ICU Medical, Inc. (NASDAQ: ICUI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,314 shares of the medical instruments supplier's stock, valued at approximately $3,711,000. Emerald Investment Advisers LLC owned about 0.10%
California State Teachers Retirement System grew its stake in shares of ICU Medical, Inc. (NASDAQ: ICUI) by 25.2% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 27,512 shares of the medical instruments supplier's stock after purchasing an additional 5,536 shares during the period.
ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.